HEADLINE: Inconsistent drug approvals across EU threatened patient safety and market access.
Marketing authorisation; GMP compliance; qualified person; pharmacovigilance
Recall, suspension, fines
Mandatory Deadline: Active
Affected HS Codes: 30
Issuing Authority: European Medicines Agency (EMA)